{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.02 vs. cons $1.00",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core sales growth",
      "prediction": "BEAT",
      "answer": "pred ~3.8% vs. cons 3.5%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~23.7% vs. cons 23.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$4.27 midpoint vs. cons $4.24 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core sales growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.75% midpoint vs. cons 3.75% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating-margin expansion guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~25 bps vs. cons 25 bps (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.4,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 beat and slightly higher FY2026 EPS midpoint should support the initial reaction, but the implied second-half EPS is only ~$2.18 versus ~$2.17 embedded in prior guidance after a ~$1.02 Q2 result. Limited out-period upside should constrain estimate revisions and cause part of the day-1 gain to fade.",
  "day5_confidence": "MEDIUM"
}